UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

May 1, 2012 (April 26, 2012)
Date of Report (Date of earliest event reported)

 

HCP, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Maryland

 

001-08895

 

33-0091377

(State of Incorporation)

 

(Commission File Number)

 

(IRS Employer

 

 

 

 

Identification Number)

 

3760 Kilroy Airport Way

Suite 300

Long Beach, California 90806

(Address of principal executive offices) (Zip Code)

 

(562) 733-5100

(Registrant’s telephone number, including area code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

 

Item  5.07                  Submission of Matters to a Vote of Security Holders.

 

HCP, Inc. (the “Company”), a Maryland corporation, held its Annual Meeting of Stockholders on April 26, 2012 (the “Annual Meeting”).  At the Annual Meeting there were present, in person or by proxy, 372,855,927 shares of the Company’s common stock, which represented approximately 90.85% of the shares entitled to vote and constituted a quorum.

 

Set forth below are the voting results of the three proposals considered and voted upon at the Annual Meeting, all of which were described in the Company’s definitive Proxy Statement, filed with the Securities and Exchange Commission on March 13, 2012.

 

Proposal 1.  All of the nominees listed below were elected to the Board of Directors of the Company and each received the affirmative vote of a majority of the votes cast at the Annual Meeting.

 

 

 

For

 

Against

 

Abstain

 

Broker Non-
Votes

 

% of Votes Supporting

 

 

 

 

 

 

 

 

 

 

 

 

 

James F. Flaherty III

 

336,124,359

 

4,852,630

 

517,203

 

31,361,735

 

98.58%

 

 

 

 

 

 

 

 

 

 

 

 

 

Christine N. Garvey

 

337,240,410

 

3,985,465

 

268,317

 

31,361,735

 

98.83%

 

 

 

 

 

 

 

 

 

 

 

 

 

David B. Henry

 

337,726,697

 

3,489,692

 

277,803

 

31,361,735

 

98.98%

 

 

 

 

 

 

 

 

 

 

 

 

 

Lauralee E. Martin

 

332,743,981

 

8,474,374

 

275,837

 

31,361,735

 

97.52%

 

 

 

 

 

 

 

 

 

 

 

 

 

Michael D. McKee

 

336,818,006

 

3,842,633

 

833,553

 

31,361,735

 

98.87%

 

 

 

 

 

 

 

 

 

 

 

 

 

Peter L. Rhein

 

333,822,045

 

7,384,109

 

288,038

 

31,361,735

 

97.84%

 

 

 

 

 

 

 

 

 

 

 

 

 

Kenneth B. Roath

 

339,896,950

 

1,312,544

 

284,698

 

31,361,735

 

99.62%

 

 

 

 

 

 

 

 

 

 

 

 

 

Joseph P. Sullivan

 

335,609,740

 

5,580,680

 

303,772

 

31,361,735

 

98.36%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proposal 2.  The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2012 was approved at the Annual Meeting.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

 

% of Votes Supporting

 

 

 

 

 

 

 

 

 

 

 

366,756,009

 

5,730,293

 

369,625

 

N/A

 

98.46%

 

 

Proposal 3.  The advisory vote to approve executive compensation was approved at the Annual Meeting.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

 

% of Votes Supporting

 

 

 

 

 

 

 

 

 

 

 

325,116,518

 

11,998,071

 

4,379,603

 

31,361,735

 

96.44%

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:  May 1, 2012

 

 

 

 

 

 

HCP, Inc.

 

 

 

 

 

By:

/s/ Timothy M. Schoen

 

 

Timothy M. Schoen

 

 

Executive Vice President and

 

 

Chief Financial Officer

 

3